BioJungboMoaKRMediMoa
StructureMoaOncology · CNS · cardio-metabolic · ADC catalog
FamiliesCompareAnalyzeMethodology

Search: PCSK9

10 hits · All families

검색 결과 보내기 · 10건
  • CompoundOral PCSK9i amide SAR analogPCSK9 inhibitor chemical & modality series · DerivativePCSK9 / LDL-C
  • CompoundOral PCSK9i fluoro-macrocycle analogPCSK9 inhibitor chemical & modality series · DerivativePCSK9 / LDL-C
  • FamilyPCSK9 inhibitor chemical & modality seriesPCSK9 / LDL-C
  • CompoundPCSK9-binding macrocyclic peptide pharmacophorePCSK9 inhibitor chemical & modality series · ScaffoldPCSK9 / LDL-C
  • CompoundAlirocumab (Praluent)PCSK9 inhibitor chemical & modality series · DrugPCSK9 / LDL-C
  • CompoundEnlicitide (Lipfendra)PCSK9 inhibitor chemical & modality series · DrugPCSK9 / LDL-C
  • CompoundEvolocumab (Repatha)PCSK9 inhibitor chemical & modality series · DrugPCSK9 / LDL-C
  • CompoundInclisiran (Leqvio)PCSK9 inhibitor chemical & modality series · DrugPCSK9 / LDL-C
  • CompoundLerodalcibep (LIB003)PCSK9 inhibitor chemical & modality series · DrugPCSK9 / LDL-C
  • CompoundMK-0616 (enlicitide development code)PCSK9 inhibitor chemical & modality series · DerivativePCSK9 / LDL-C

Substructure search: Search again with SMARTS/SMILES

StructureMoa

Structures, SAR, similarity, and drug-class connections

Exploration ranksCNS deep analysisInsightsStructure familiesMechanism classesBriefsUpdatesADC payloadSMILES mapKRAS G12CRSS
AboutMethodologyPrivacy Policy

Contact · contact@biojungbomoa.com

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

© 2026 StructureMoa · 2 weeks manual refresh · /analyze · Last refresh 7/20/2026, 2:10:30 AM